Clinical Research

Cell to Cure ApS

Address
Kajeroedgaard 9

Sponsor Overview

assignment
3
sponsored trials
science
0
molecules
location_city
5
research centres
public
1
country
person_search
5
investigators

Specializations

Neurodevelopmental disorders and gastrointestinal symptoms

Clinical activity includes autism spectrum disorder with associated gastrointestinal symptoms, reflecting interest in conditions where immune and regenerative cell-based approaches are being explored.

  • Autism spectrum disorder
  • Gastrointestinal symptoms
  • Mesenchymal stromal cells

The research focus extends to pediatric and symptom-linked presentations that combine neurodevelopmental and digestive disease domains.

Cardiac regenerative medicine

Another area of interest is non-ischemic heart failure with reduced ejection fraction, with attention on restoring cardiac function in recently diagnosed patients.

  • Non-ischemic heart failure with reduced ejection fraction
  • Cardiac function
  • Allogeneic cell therapy

This supports work in cardiovascular disease where cell-based interventions are being investigated for functional recovery.

Wound healing in diabetes

The sponsor also funds research in diabetic foot ulcus, a severe complication of diabetes involving impaired tissue repair and chronic ulceration.

  • Diabetic foot ulcus
  • Chronic wound healing
  • Adipose tissue-derived cells

Interest in this area centers on lower-limb ulcer management and regenerative support for difficult-to-heal diabetic wounds.

Sponsored Trials

Trial Name Country Status
A Danish, double-blind, randomized placebo-controlled clinical trial evaluating allogeneic adipose tissue derived mesenchymal stromal cell therapy in patients with recently diagnosed non-ischemic heart failure with reduced ejection fraction.Denmark DenmarkNot Recruiting
An open label safety and efficacy study of allogenic adipose tissue-derived mesenchymal stromal cells on autism and gastrointestinal symptomsDenmark DenmarkNot Yet Recruiting
Evaluation of Mesenchymal Stem Cells in the Treatment of Diabetic Foot Ulcers: A Phase I Pilot StudyDenmark DenmarkNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 5 sites collaborated multiple times

This sponsor has worked with 5 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Cardiovascular Diseases1 trial
    359 other sponsors
  • 2.
    Digestive System Diseases1 trial
    280 other sponsors
  • 3.
    Immune system processes1 trial
    65 other sponsors
  • 4.
    Investigative Techniques1 trial
    35 other sponsors
  • 5.
    Mental Disorders1 trial
    150 other sponsors
  • 6.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors

Partnered Research Centres

5 centres
location_city
assignment58
Bispebjerg Hospital
Address
Nielsine Nielsens Vej 6A, 2400 Copenhagen
Learn morearrow_forward
location_city
assignment1
Cell to Cure ApS
Address
Dronningensgade 97a, 7000 Fredericia
Learn morearrow_forward
location_city
assignment296
Herlev Hospital
Address
Dyrehavevej 29, 3400 Herlev
Learn morearrow_forward
location_city
assignment719
Rigshospitalet
Address
Blegdamsvej 9, 2100 Copenhagen
Learn morearrow_forward
location_city
assignment62
Roskilde University
Address
Kogevej 7, 4000 Roskilde
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Cell to Cure ApS.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.